Becton Dickinson SG&A Expenses 2010-2024 | BDX

Becton Dickinson sg&a expenses for the twelve months ending June 30, 2024 were $4.739B, a 0.55% decline year-over-year.

  • Becton Dickinson annual sg&a expenses for 2023 were $4.719B, a 0.21% increase from 2022.
  • Becton Dickinson annual sg&a expenses for 2022 were $4.709B, a 0.21% decline from 2021.
  • Becton Dickinson annual sg&a expenses for 2021 were $4.719B, a 12.76% increase from 2020.

Becton Dickinson SG&A Expenses 2010-2024 | BDX

  • Becton Dickinson annual sg&a expenses for 2023 were $4.719B, a 0.21% increase from 2022.
  • Becton Dickinson annual sg&a expenses for 2022 were $4.709B, a 0.21% decline from 2021.
  • Becton Dickinson annual sg&a expenses for 2021 were $4.719B, a 12.76% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
West Pharmaceutical Services (WST)$21.5B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M